These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25142822)

  • 1. Regulatory considerations for the classification of video monitoring in dissolution testing.
    Tieu K; Salt A; Wirges J; Grove GN
    AAPS PharmSciTech; 2014 Dec; 15(6):1611-8. PubMed ID: 25142822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note.
    Gao Z; Moore T; Smith AP; Doub W; Westenberger B; Buhse L
    AAPS PharmSciTech; 2007 Oct; 8(4):E82. PubMed ID: 18181543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.
    Yu LX; Carlin AS; Amidon GL; Hussain AS
    Int J Pharm; 2004 Feb; 270(1-2):221-7. PubMed ID: 14726137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    Son YJ; McConville JT
    Int J Pharm; 2009 Dec; 382(1-2):15-22. PubMed ID: 19665533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of tablet dissolution.
    Nott KP
    Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the use of a 200 ml vessel suitable for dissolution of low dose drug products?
    Crail DJ; Tunis A; Dansereau R
    Int J Pharm; 2004 Jan; 269(1):203-9. PubMed ID: 14698592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
    Novick S; Shen Y; Yang H; Peterson J; LeBlond D; Altan S
    J Biopharm Stat; 2015; 25(2):351-71. PubMed ID: 25357203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical properties of the USP dissolution test with pooled samples.
    Saccone CD; Meneces NS; Tessore J
    PDA J Pharm Sci Technol; 2005; 59(5):310-9. PubMed ID: 16316066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
    Chiang PC; Ran Y; Chou KJ; Cui Y; Sambrone A; Chan C; Hart R
    AAPS PharmSciTech; 2012 Jun; 13(2):713-22. PubMed ID: 22562615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate approaches for the development of quality control in-situ fiber optics dissolution methods for fixed-dose combination tablets.
    Medendorp J; Colón I; Ryan T
    Drug Dev Ind Pharm; 2019 Jun; 45(6):999-1008. PubMed ID: 30905176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving calibration of 3-D video oculography systems.
    Schreiber K; Haslwanter T
    IEEE Trans Biomed Eng; 2004 Apr; 51(4):676-9. PubMed ID: 15072222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the probability of passing the USP dissolution test.
    Wang H
    J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.
    May S; Jensen B; Weiler C; Wolkenhauer M; Schneider M; Lehr CM
    Pharm Res; 2014 Nov; 31(11):3211-24. PubMed ID: 24852894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
    Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crescent-shaped spindle for improved dissolution testing.
    Qureshi SA
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):55-65. PubMed ID: 20144452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camera calibration from video of a walking human.
    Lv F; Zhao T; Nevatia R
    IEEE Trans Pattern Anal Mach Intell; 2006 Sep; 28(9):1513-8. PubMed ID: 16929736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.